Sei J. Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sei J. Lee has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Kingsbury Smith
Division of Geriatrics University of California, San Francisco San Francisco California USA
4 shared publications - Abdelaziz Elnaggar
Department of Community Health Systems, School of Nursing, University of California San Francisco, CA, USA
3 shared publications - Alexandra K. Lee
Division of Geriatrics University of California San Francisco California USA
3 shared publications - Allyson Cook Chapman
Division of Palliative Care, Department of Internal Medicine, University of California, San Francisco, San Francisco
3 shared publications - Irena Cenzer
Division of Geriatrics University of California, San Francisco San Francisco California USA
3 shared publications - Julien Cobert
Anesthesia Service, San Francisco VA Health Care System, University of California, San Francisco, San Francisco, CA, United States of America; Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA, United States of America
3 shared publications
Latest Publications
- Open Access
- 26 September 2026
- Published by Wiley in Journal of the American Geriatrics Society
All Hypoglycemia Is Not Created Equal
A Proposed Hypoglycemia Taxonomy: Differences in Frequency, Detection, and Evidence of Harms.
- 26 September 2026
- Published by Wiley in Journal of the American Geriatrics Society
Open AccessAll Hypoglycemia Is Not Created Equal
A Proposed Hypoglycemia Taxonomy: Differences in Frequency, Detection, and Evidence of Harms.
- Open Access
- 10 December 2025
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (3) , 793-799
Burden of Hypoglycemia and Hyperglycemia in Insulin‐Treated Veterans Affairs Nursing Home Residents
Background: To avoid potential harms from hypoglycemia, guidelines for diabetes management in nursing home residents recommend less intensive glycemic control. However, it is unknown how often hypoglycemia and hyperglycemia co‐occur in the same resident, which may present challenges for deintensification of diabetes treatment. Methods: We conducted a cross‐sectional study of insulin‐treated Veterans Affairs nursing home residents with diabetes aged ≥ 65 years from 1/1/2016 to 9/30/2019 with a nursing home stay ≥ 7 days. Residents missing fingerstick glucose measurements during the first 7 days were excluded. We classified insulin use as basal insulin only, bolus insulin only, or a combination of basal and bolus insulin. We examined the prevalence of fingerstick‐detected hypoglycemia (< 54 mg/dL, 54–69 mg/dL) and hyperglycemia (250–299, 300–349, 350–399, ≥ 400 mg/dL) overall and stratified by type of insulin. Results: Among 12,031 insulin‐treated residents, the mean age was 74.4 years, 98% were male, and 22% were non‐White. Most residents ( n = 7176, 59.6%) were treated with a combination of basal and bolus insulin, 31.8% ( n = 3829) used bolus insulin alone and 8.5% ( n = 1026) used basal insulin alone. During the first 7 days of the nursing home stay, 5730 (48%) had hyperglycemia ≥ 250 mg/dL alone, 862 (7%) had hypoglycemia < 70 mg/dL alone, 1488 (12%) had both hyperglycemia and hypoglycemia, and 3951 (33%) had neither hypoglycemia nor hyperglycemia. Residents on a combination of basal and bolus insulin were more likely to have hyperglycemia ≥ 400 mg/dL (10.2% vs. 3.6% for bolus insulin alone and 1.6% for basal insulin alone, p < 0.001) and to have hypoglycemia < 54 mg/dL (8.4% vs. 2.9% for bolus alone vs. 5.9% for basal alone, p < 0.001). Conclusion: Nearly two‐thirds of nursing home residents with hypoglycemia also had hyperglycemia. Efforts to de‐intensify diabetes treatment in nursing homes will need to address the high burden of hyperglycemia by tailoring the timing and type of insulin to minimize hypoglycemia while also not worsening hyperglycemia.
- 10 December 2025
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (3) , 793-799
Open AccessBurden of Hypoglycemia and Hyperglycemia in Insulin‐Treated Veterans Affairs Nursing Home Residents
Background: To avoid potential harms from hypoglycemia, guidelines for diabetes management in nursing home residents recommend less intensive glycemic control. However, it is unknown how often hypoglycemia and hyperglycemia co‐occur in the same resident, which may present challenges for deintensification of diabetes treatment. Methods: We conducted a cross‐sectional study of insulin‐treated Veterans Affairs nursing home residents with diabetes aged ≥ 65 years from 1/1/2016 to 9/30/2019 with a nursing home stay ≥ 7 days. Residents missing fingerstick glucose measurements during the first 7 days were excluded. We classified insulin use as basal insulin only, bolus insulin only, or a combination of basal and bolus insulin. We examined the prevalence of fingerstick‐detected hypoglycemia (< 54 mg/dL, 54–69 mg/dL) and hyperglycemia (250–299, 300–349, 350–399, ≥ 400 mg/dL) overall and stratified by type of insulin. Results: Among 12,031 insulin‐treated residents, the mean age was 74.4 years, 98% were male, and 22% were non‐White. Most residents ( n = 7176, 59.6%) were treated with a combination of basal and bolus insulin, 31.8% ( n = 3829) used bolus insulin alone and 8.5% ( n = 1026) used basal insulin alone. During the first 7 days of the nursing home stay, 5730 (48%) had hyperglycemia ≥ 250 mg/dL alone, 862 (7%) had hypoglycemia < 70 mg/dL alone, 1488 (12%) had both hyperglycemia and hypoglycemia, and 3951 (33%) had neither hypoglycemia nor hyperglycemia. Residents on a combination of basal and bolus insulin were more likely to have hyperglycemia ≥ 400 mg/dL (10.2% vs. 3.6% for bolus insulin alone and 1.6% for basal insulin alone, p < 0.001) and to have hypoglycemia < 54 mg/dL (8.4% vs. 2.9% for bolus alone vs. 5.9% for basal alone, p < 0.001). Conclusion: Nearly two‐thirds of nursing home residents with hypoglycemia also had hyperglycemia. Efforts to de‐intensify diabetes treatment in nursing homes will need to address the high burden of hyperglycemia by tailoring the timing and type of insulin to minimize hypoglycemia while also not worsening hyperglycemia.
- Open Access
- 23 October 2025
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (1) , 269-271
Six‐Month Prognostic Tool for Community‐Dwelling People With Dementia
- 23 October 2025
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (1) , 269-271
Open AccessSix‐Month Prognostic Tool for Community‐Dwelling People With Dementia
- Open Access
- 28 May 2025
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 69 (2) , 107736
Time to Benefit for Lung Cancer Screening: A Systematic Review and Survival Meta-Analysis
- 28 May 2025
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 69 (2) , 107736
Open AccessTime to Benefit for Lung Cancer Screening: A Systematic Review and Survival Meta-Analysis
- 20 May 2025
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 73 (7) , 2003-2005
Geriatricians: Maximizing Impact Now While Aiming for a Stronger Future
- 20 May 2025
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 73 (7) , 2003-2005
Geriatricians: Maximizing Impact Now While Aiming for a Stronger Future
- Open Access
- 1 May 2023
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 183 (5) , 499
Improving Clinical Applicability of Mortality Prediction Models Among Persons With Dementia—Reply
In Reply We appreciate the letter from Dr Mooldijk and colleagues regarding our study that reported on the development and external validation of a
- 1 May 2023
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 183 (5) , 499
Open AccessImproving Clinical Applicability of Mortality Prediction Models Among Persons With Dementia—Reply
In Reply We appreciate the letter from Dr Mooldijk and colleagues regarding our study that reported on the development and external validation of a
- Open Access
- 3 January 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (1)
Preoperative Factors Predict Memory Decline After Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention in an Epidemiological Cohort of Older Adults
Background: Durable memory decline may occur in older adults after surgical (coronary artery bypass grafting [CABG]) or nonsurgical (percutaneous coronary intervention) coronary revascularization. However, it is unknown whether individual memory risk can be predicted. We reanalyzed an epidemiological cohort of older adults to predict memory decline at ≈1 year after revascularization. Methods and Results: We studied Health and Retirement Study participants who underwent CABG or percutaneous coronary intervention at age ≥65 years between 1998 and 2015 and participated in ≥1 biennial postprocedure assessment. Using a memory score based on direct and proxy cognitive tests, we identified participants whose actual postprocedure memory score was 1–2 (“mild”) or >2 (“major”) SDs below expected postprocedure performance. We modeled probability of memory decline using logistic regression on preoperatively known factors and evaluated model discrimination and calibration. A total of 1390 participants (551 CABG, 839 percutaneous coronary intervention) underwent CABG/percutaneous coronary intervention at 75±6 years old; 40% were women. The cohort was 83% non‐Hispanic White, 8.4% non‐Hispanic Black, 6.4% Hispanic ethnicity, and 1.7% from other groups masked by the HRS (Health and Retirement Study) to preserve participant confidentiality. At a median of 1.1 (interquartile range, 0.6–1.6) years after procedure, 267 (19%) had mild memory decline and 88 (6.3%) had major memory decline. Factors predicting memory decline included older age, frailty, and off‐pump CABG; obesity was protective. The optimism‐corrected area under the receiver operator characteristic curve was 0.73 (95% CI, 0.71–0.77). A cutoff of 50% probability of memory decline identified 14% of the cohort as high risk, and was 94% specific and 30% sensitive for late memory decline. Conclusions: Preoperative factors can be used to predict late memory decline after coronary revascularization in an epidemiological cohort with high specificity.
- 3 January 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (1)
Open AccessPreoperative Factors Predict Memory Decline After Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention in an Epidemiological Cohort of Older Adults
Background: Durable memory decline may occur in older adults after surgical (coronary artery bypass grafting [CABG]) or nonsurgical (percutaneous coronary intervention) coronary revascularization. However, it is unknown whether individual memory risk can be predicted. We reanalyzed an epidemiological cohort of older adults to predict memory decline at ≈1 year after revascularization. Methods and Results: We studied Health and Retirement Study participants who underwent CABG or percutaneous coronary intervention at age ≥65 years between 1998 and 2015 and participated in ≥1 biennial postprocedure assessment. Using a memory score based on direct and proxy cognitive tests, we identified participants whose actual postprocedure memory score was 1–2 (“mild”) or >2 (“major”) SDs below expected postprocedure performance. We modeled probability of memory decline using logistic regression on preoperatively known factors and evaluated model discrimination and calibration. A total of 1390 participants (551 CABG, 839 percutaneous coronary intervention) underwent CABG/percutaneous coronary intervention at 75±6 years old; 40% were women. The cohort was 83% non‐Hispanic White, 8.4% non‐Hispanic Black, 6.4% Hispanic ethnicity, and 1.7% from other groups masked by the HRS (Health and Retirement Study) to preserve participant confidentiality. At a median of 1.1 (interquartile range, 0.6–1.6) years after procedure, 267 (19%) had mild memory decline and 88 (6.3%) had major memory decline. Factors predicting memory decline included older age, frailty, and off‐pump CABG; obesity was protective. The optimism‐corrected area under the receiver operator characteristic curve was 0.73 (95% CI, 0.71–0.77). A cutoff of 50% probability of memory decline identified 14% of the cohort as high risk, and was 94% specific and 30% sensitive for late memory decline. Conclusions: Preoperative factors can be used to predict late memory decline after coronary revascularization in an epidemiological cohort with high specificity.